Today on #NationalAccessibleAirTravelDay, we’re joining @Allwheelsup to recognize the need for safer, more inclusive air travel for people who use wheelchairs and other mobility aids. Learn more about the organization:

Our #Dynamos came together for Dyne’s 4th annual FORCE for Good Service Day in partnership with @LS_Cares to support local organizations including: @SCFG @CommunityFarms @communityserv @c2cboston @sowma @MysticMyRWA @MspcaAngell. Thank you to everyone who made it a success!

International #MyotonicDystrophy Awareness Day is one month away!. Help raise awareness of DM and learn how to get involved: . #myotonicdystrophyawareness

Now hiring!. Join Dyne on our mission to deliver functional improvement for people living with genetically driven neuromuscular diseases. If you’re a bold thinker ready to make a real impact, join our team of #Dynamos. Explore open roles:

Our Dynamos joined the DM community for Myotonic Dystrophy in Motion Awareness Month to show support for individuals and families. Thanks to everyone who participated!

One month to go until #WorldDuchenneAwarenessDay on September 7. This year’s theme is “Family: The Heart of Care,” honoring the vital role families play for those living with #Duchenne. Learn more & get involved: . #WDAD25

Dr. Kirk Taylor, President & CEO of @MALifeSciences, joined our FORCEs in Biotech series. His path from music to medicine to biotech is a masterclass in career development. Takeaways: collaboration & trust are non-negotiable as we bring life-changing therapies to patients.

Today we announced that the @US_FDA has granted Breakthrough Therapy Designation to DYNE-251 for the treatment of patients with DMD amenable to exon 51 skipping. Read here:

Celebrating our incredible #Dynamo interns and co-ops this National Intern Day! Thank you for your energy, dedication and drive as we work to bring functional improvement to people living with genetically driven neuromuscular diseases.

Today we shared our Q2 2025 results, highlighting progress for our #DMD and #DM1 programs. Read here: $DYN

A big congratulations to our #Dynamos who were recently promoted! . Your hard work, dedication and passion for our mission continue to drive Dyne forward as we work to deliver functional improvement for people living with genetically driven neuromuscular diseases.

This July, join the @MyotonicStrong community for Myotonic Dystrophy in Motion Awareness Month to support wellness for people living with DM. Get involved with weekly activities, expert webinars and ways to connect:

On Dyne Science Day, our #Dynamos shared the research and innovation driving our goal to deliver meaningful functional improvement for people with neuromuscular diseases. Grateful for a team that never stops pushing science forward.

This #WorldFSHDDay, we're proud to support the @FSHDSociety and raise awareness of FSHD and its impact – including the loss of the ability to smile. Learn more and get involved:

Dyne CIO Oxana Beskrovnaya is joining leaders at #BIO2025 to discuss what’s driving the “RNAissance” and how RNA therapeutics are reshaping drug development. Learn more:

We’re excited to join the #Duchenne community for the @ParentProjectMD’s 2025 Annual Conference! Register to visit us either virtually or in person at our booth:

DYNE-101 received Breakthrough Therapy Designation for DM1 from @US_FDA. New long-term data support its promise to deliver meaningful functional improvement as we advance toward potential U.S. Accelerated Approval. Learn more: $DYN

Tomorrow, June 17, we will host a webcast to provide an update on DYNE-101 in DM1 Join us at 8:00 a.m. ET: $DYN

We were thrilled to recently host Dr. Johanna Hamel at Dyne. She shared how expanding access to research through remote assessments and patient registries helps capture the full story of #MyotonicDystrophy.

FSHD Connect, hosted by @FSHDSociety and FSHD Europe, brings together individuals living with #FSHD, their families, researchers and advocates. We look forward to engaging with the community and discussing the latest research and progress: